Endometriosis is a debilitating disease that still needs surgery to be confirmed. Endometriosis is associated with increased plasma levels of phosphatidylcholines. 18F-fluorocholine ([18F]FCH) is a radiopharmaceutical that is metabolized to phosphatidylcholine inside the cells and can be traced by positron emission tomography (PET). Here we evaluate [18F]FCH as a potential tool for the noninvasive diagnosis of peritoneal endometriosis. Adult female Wistar rats had autologous uterine fragments dissected and grafted to the peritoneal wall to model peritoneal endometriosis. Ex vivo biodistribution assay and PET imaging studies were performed 30 minutes after [18F]FCH administration. The [18F]FCH uptake was 3-fold higher in endometriotic implant tissues than in muscle or peritoneum. Positron emission tomography imaging revealed the grafted uterine tissue in contrast to surrounding structures. Region-of-interest analysis of the reconstructed images showed higher accumulation of [18F]FCH by endometriotic lesions, 0.34 (0.04)% of injected dose per gram of tissue (ID/g), in comparison with muscle tissue, 0.08 (0.01)% ID/g. However, sham implants with fat tissue were also detectable in PET imaging. These preliminary findings of [18F]FCH uptake by ectopic uterine tissue implants and their localization by PET imaging encourage the future evaluation of this technique to detect small superficial endometriosis lesions in humans. Study protocols need to be further perfected and adapted for tests in women with endometriosis.
MeulemanCVandenabeeleBFieuwsSSpiessensCTimmermanDD’HoogheT. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.
2.
DouglasCRotimiO. Extragenital endometriosis—a clinicopathological review of a Glasgow hospital experience with case illustrations. J Obstet Gynaecol. 2004;24(7):804–808.
SantanamNMurphyAAParthasarathyS. Macrophages, oxidation, and endometriosis. Ann N Y Acad Sci. 2002;955:183–198; discussion 119-200, 396-406.
5.
DulebaAJ. Diagnosis of endometriosis. Obstet Gynecol Clin North Am. 1997;24(2):331–346.
6.
VercelliniPFedeleLAimiGPietropaoloGConsonniDCrosignaniPG. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod. 2007;22(1):266–271.
7.
DunselmanGAVermeulenNBeckerC. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.
8.
BallardKDSeamanHEde VriesCSWrightJT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study—part 1. Bjog. 2008;115(11):1382–1391.
9.
BrosensIPuttemansPCampoRGordtsSKinkelK. Diagnosis of endometriosis: pelvic endoscopy and imaging techniques. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):285–303.
10.
MarchinoGLGennarelliGEnriaRBongioanniFLipariGMassobrioM. Laparoscopic visualization with histologic confirmation represents the best available option to date in the diagnosis of endometriosis. Fertil Steril. 2005;84(1):38.
11.
StrattonPWinkelCPremkumarA. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril. 2003;79(5):1078–1085.
12.
MayKEConduit-HulbertSAVillarJKirtleySKennedySHBeckerCM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16(6):651–674.
13.
BorgheseBTostJde SurvilleM. Identification of susceptibility genes for peritoneal, ovarian, and deep infiltrating endometriosis using a pooled sample-based genome-wide association study. Biomed Res Int. 2015;2015:461024.
14.
BorgheseBMondonFNoelJC. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol. 2008;22(11):2557–2562.
15.
VoukKHevirNRibic-PuceljM. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod. 2012;27(10):2955–2965.
16.
DuttaMAnithaMSmithPB. Metabolomics reveals altered lipid metabolism in a mouse model of endometriosis. J Proteome Res. 2016;15(8):2626–2633.
17.
PhelpsME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A. 2000;97(16):9226–9233.
18.
ColemanRE. Clinical PET in oncology. Clin Positron Imaging. 1998;1(1):15–30.
19.
PapathanassiouDBruna-MurailleCLiehnJCNguyenTDCureH. Positron emission tomography in oncology: present and future of PET and PET/CT. Crit Rev Oncol Hematol. 2009;72(3):239–254.
20.
FastrezMNogaredeCTondeurMSirtaineNRozenbergS. Evaluation of 18FDG PET-CT in the diagnosis of endometriosis: a prospective study. Reprod Sci. 2011;18(6):540–544.
21.
JeffryLKerrouKCamatteS. Endometriosis with FDG uptake on PET. Eur J Obstet Gynecol Reprod Biol. 2004;117(2):236–239.
22.
SetubalAMaiaSLowenthalCSidiropoulouZ. FDG-PET value in deep endometriosis. Gynecol Surg. 2011;8(3):305–309.
23.
HaraT. 18F-fluorocholine: a new oncologic PET tracer. J Nucl Med. 2001;42(12):1815–1817.
24.
DeGradoTRColemanREWangS. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110–117.
25.
Ramirez de MolinaARodriguez-GonzalezAGutierrezR. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296(3):580–583.
26.
PriceDTColemanRELiaoRPRobertsonCNPolascikTJDeGradoTR. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168(1):273–280.
27.
DeGradoTRReimanREPriceDTWangSColemanRE. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med. 2002;43(1):92–96.
28.
ReisFMPetragliaFTaylorRN. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update. 2013;19(4):406–418.
29.
ChagovetsVVWangZKononikhinAS. Endometriosis foci differentiation by rapid lipid profiling using tissue spray ionization and high resolution mass spectrometry. Sci Rep. 2017;7(1):2546.
30.
SilveiraMBFerreiraSMNascimentoLT. Preclinical acute toxicity, biodistribution, pharmacokinetics, radiation dosimetry and microPET imaging studies of [(18)F]fluorocholine in mice. Appl Radiat Isot. 2016;116:92–101.
31.
VernonMWWilsonEA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694.
BergeronMCadoretteJBeaudoinJF. Performance evaluation of the LabPET APD-based digital PET scanner. IEEE Trans Nucl Sci. 2009;56(1):10–16.
34.
ZhengQHGardnerTARaikwarS. [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. Bioorg Med Chem. 2004;12(11):2887–2893.
35.
BansalAShuyanWHaraTHarrisRADegradoTR. Biodisposition and metabolism of [(18)F]fluorocholine in 9 L glioma cells and 9 L glioma-bearing fisher rats. Eur J Nucl Med Mol Imaging. 2008;35(6):1192–1203.
36.
AbraoMSDiasJAJrBellelisPPodgaecSBautzerCRGromatskyC. Endometriosis of the ureter and bladder are not associated diseases. Fertil Steril. 2009;91(5):1662–1667.
37.
UchiideIIharaTSugamataM. Pathological evaluation of the rat endometriosis model. Fertil Steril. 2002;78(4):782–786.
38.
KennedySBergqvistAChapronC. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20(10):2698–2704.
